Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel

Markets GlobeNewswire By GlobeNewswire 01 Oct 2026 20:03 1 min read
Inspire Medical Systems, Inc. Announces Approval of New Hypoglossal Nerve Stimulation CPT® Codes by the AMA Editorial Panel

MINNEAPOLIS, Oct. 01, 2026 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), today announced that the American Medical Association (AMA) CPT® Editorial Panel has approved the establishment of a new set of Current Procedural Terminology (CPT®) codes that accurately describe and include the Inspire V system. The new Category I codes are scheduled to take effect on January 1, 2028.

Covered in this story

What has happened since

Price move measured from the close nearest publication to the latest quote.

Analyst targets on Camden Property Trust

Published targets verified against independent reporting and tracked to their dates. Not recommendations from Dalsna Finance.

Call it yourself

No member calls on $CPT yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.

Make the first call on Camden Property Trust →
Read the full story on GlobeNewswire → Opens the original article on www.globenewswire.com

Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.